pubmed.ncbi.nlm.nih.gov

Male circumcision, HIV and sexually transmitted infections: a review - PubMed

Review

Male circumcision, HIV and sexually transmitted infections: a review

Natasha Larke. Br J Nurs. 2010.

Abstract

Three randomized controlled trials in sub-Saharan Africa have shown that circumcision reduces the risk of acquiring HIV infection in men by approximately 60%. In this paper, we review the evidence that male circumcision protects against infection with HIV and other sexually transmitted infections (STIs) in men and their female partners. Data from the clinical trials indicate that circumcision may be protective against genital ulcer disease, Herpes simplex type 2, Trichomonas vaginalis and human papillomavirus infection in men. No evidence exists of a protective effect against Chlamydia trachomatis or Neisseria gonorrhea. There is weak evidence that circumcision has a direct protective effect on HIV infection in women, although there is likely to be an indirect benefit, since HIV prevalence is likely to be lower in circumcised male partners. Although there is little evidence from the trials of serious adverse events from the procedure and of behavioural risk compensation among circumcised men, essential operational research is being conducted to evaluate these key issues outside the trial setting as circumcision services are expanded. Following the publication of the clinical trial results in early 2007, the World Health Organization/UNAIDS has advised that promotion of male circumcision should be included as an additional HIV strategy for the prevention of heterosexually acquired HIV infection in men in areas of high HIV prevalence. As circumcision services are expanded in settings where resources are limited, non-physician providers including nurses will play an important role in the provision of services.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Amir M, Raja MH, Niaz WA. Neonatal circumcision with Gomco clamp – a hospital-based retrospective study of 1000 cases. J Pak Med Assoc. 2000;50(7):224–7. - PubMed
    1. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2(11):e298. - PMC - PubMed
    1. Auvert B, Sobngwi-Tambekou J, Cutler E, et al. Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: results of a randomized controlled trial conducted in Orange Farm, South Africa. J Infect Dis. 2009;199(1):14–19. - PMC - PubMed
    1. Baeten JM, Donnell D, Kapiga SH, et al. Male circumcision and risk of male-to-female HIV–1 transmission: a multinational prospective study in African HIV–1–serodiscordant couples. AIDS. 2010;24(5):737–44. - PMC - PubMed
    1. Bailey RC. Scaling Up Circumcision Programmes: the Road From Evidence to Practice; 4th International AIDS Society Conference of HIV Pathogenesis, Treatment and Prevention; Sydney, Australia. 2007; [accessed 16 May 2010]. 2007. Abstract TUPL101. tinyurl.com/TUPL-101.

Publication types

MeSH terms